These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 29322269)
1. Prognostic value of simultaneous Kim YI; Cheon GJ; Kang SY; Paeng JC; Kang KW; Lee DS; Chung JK EJNMMI Res; 2018 Jan; 8(1):2. PubMed ID: 29322269 [TBL] [Abstract][Full Text] [Related]
3. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer. Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630 [TBL] [Abstract][Full Text] [Related]
4. Correlation between apparent diffusion coefficients and metabolic parameters in hypopharyngeal squamous cell carcinoma: A prospective study with integrated PET/MRI. Zhang L; Song T; Meng Z; Huang C; Chen X; Lu J; Xian J Eur J Radiol; 2020 Aug; 129():109070. PubMed ID: 32454330 [TBL] [Abstract][Full Text] [Related]
5. Assessment of serial multi-parametric functional MRI (diffusion-weighted imaging and R2*) with (18)F-FDG-PET in patients with head and neck cancer treated with radiation therapy. Min M; Lee MT; Lin P; Holloway L; Wijesekera Dj; Gooneratne D; Rai R; Xuan W; Fowler A; Forstner D; Liney G Br J Radiol; 2016; 89(1058):20150530. PubMed ID: 26648404 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of 18F-FDG PET/MRI in patients with advanced oropharyngeal and hypopharyngeal squamous cell carcinoma. Pace L; Nicolai E; Cavaliere C; Basso L; Garbino N; Spinato G; Salvatore M Ann Nucl Med; 2021 Apr; 35(4):479-484. PubMed ID: 33575927 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity index evaluated by slope of linear regression on Kim YI; Kim YJ; Paeng JC; Cheon GJ; Lee DS; Chung JK; Kang KW Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1995-2003. PubMed ID: 28634684 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of FDG-PET and DWI in breast cancer. Kitajima K; Miyoshi Y; Yamano T; Odawara S; Higuchi T; Yamakado K Ann Nucl Med; 2018 Jan; 32(1):44-53. PubMed ID: 29134565 [TBL] [Abstract][Full Text] [Related]
9. Application of Simultaneous Huang Z; Li X; Wang Z; Meng N; Fu F; Han H; Li D; Bai Y; Wei W; Fang T; Feng P; Yuan J; Yang Y; Wang M J Magn Reson Imaging; 2022 Jul; 56(1):63-74. PubMed ID: 34888990 [TBL] [Abstract][Full Text] [Related]
10. Cervical Cancer: Associations between Metabolic Parameters and Whole Lesion Histogram Analysis Derived from Simultaneous Meyer HJ; Purz S; Sabri O; Surov A Contrast Media Mol Imaging; 2018; 2018():5063285. PubMed ID: 30154687 [TBL] [Abstract][Full Text] [Related]
11. Use of Rudžianskas V; Korobeinikova E; Rudžianskienė M; Jaselskė E; Adlienė D; Šedienė S; Kulakienė I; Padervinskis E; Jurkienė N; Juozaitytė E Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30544718 [No Abstract] [Full Text] [Related]
12. Prognostic value of combined MTV and ADC derived from baseline FDG PET/MRI in aggressive non-Hodgkins lymphoma. Husby T; Johansen H; Bogsrud TV; Hustad KV; Evensen BV; Boellaard R; Giskeødegård GF; Fagerli UM; Eikenes L BMC Cancer; 2022 Nov; 22(1):1117. PubMed ID: 36319985 [TBL] [Abstract][Full Text] [Related]
13. Pre-treatment PET/MRI based FDG and DWI imaging parameters for predicting HPV status and tumor response to chemoradiotherapy in primary oropharyngeal squamous cell carcinoma (OPSCC). Freihat O; Tóth Z; Pintér T; Kedves A; Sipos D; Cselik Z; Lippai N; Repa I; Kovács Á Oral Oncol; 2021 May; 116():105239. PubMed ID: 33640578 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of Kitajima K; Yamano T; Miyoshi Y; Katsuura T; Enoki T; Yamakado K Hell J Nucl Med; 2019; 22(1):25-35. PubMed ID: 30843007 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of MRI-assisted metabolic volumetric parameters provided by simultaneous (18)F-fluorocholine PET/MRI for primary prostate cancer characterization. Kim YI; Cheon GJ; Paeng JC; Cho JY; Kwak C; Kang KW; Chung JK; Kim EE; Lee DS Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1247-56. PubMed ID: 25759164 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer. Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649 [TBL] [Abstract][Full Text] [Related]
17. Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from Kim YI; Kim YJ; Paeng JC; Cheon GJ; Lee DS; Chung JK; Kang KW Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1787-1795. PubMed ID: 28616695 [TBL] [Abstract][Full Text] [Related]
18. Influence of volumetric 4'-[methyl- Hoshikawa H; Mori T; Maeda Y; Takahashi S; Ouchi Y; Yamamoto Y; Nishiyama Y Ann Nucl Med; 2017 Jan; 31(1):63-70. PubMed ID: 27679399 [TBL] [Abstract][Full Text] [Related]
19. Changes in serial multiparametric MRI and FDG-PET/CT functional imaging during radiation therapy can predict treatment response in patients with head and neck cancer. Trada Y; Keall P; Jameson M; Moses D; Lin P; Chlap P; Holloway L; Min M; Forstner D; Fowler A; Lee MT Eur Radiol; 2023 Dec; 33(12):8788-8799. PubMed ID: 37405500 [TBL] [Abstract][Full Text] [Related]
20. Predictive Value of Diffusion, Glucose Metabolism Parameters of PET/MR in Patients With Head and Neck Squamous Cell Carcinoma Treated With Chemoradiotherapy. Kedves A; Tóth Z; Emri M; Fábián K; Sipos D; Freihat O; Tollár J; Cselik Z; Lakosi F; Bajzik G; Repa I; Kovács Á Front Oncol; 2020; 10():1484. PubMed ID: 32983984 [No Abstract] [Full Text] [Related] [Next] [New Search]